Looking ahead – Trends in AI and R&D: From Drug Development to Personalized Patient Care Topic areas:

Session details:

• How the life science ecosystem is working together to transform oncology R&D through end-to-end AI integration from early research and target identification through the clinical development process
  
  
• Technologies enhancing understanding of complex diseases at greater speed, identification of new targets and design of new therapeutic molecules/modalities while better predicting clinical success
  
  
• Approaches to de-risk and accelerate clinical trials by enhancing patient selection and clinical trial design
  
  
• AstraZeneca's approach to partnerships and collaboration across the oncology community and beyond to discover, develop and deliver new treatments far faster and more precisely than ever before.